Literature DB >> 19414536

HMGB1 loves company.

Marco E Bianchi1.   

Abstract

HMGB1, outside of a cell, is a trigger of inflammation and a stimulus for tissue reconstruction; the balance may depend on the complexes it forms with other molecules. HMGB1 is the prime example of a danger signal that originates from the damaged self rather than from invading pathogens. HMGB1 is released by cells that die traumatically and is secreted by cells destined to die and by activated cells of the innate immunity system. As a danger signal, HMGB1 is expected to trigger inflammation, but recent reports indicate that pure recombinant HMGB1 has no proinflammatory activity and only acts as a chemoattractant and a mitogen. However, HMGB1 forms highly inflammatory complexes with ssDNA, LPS, IL-1beta, and nucleosomes, which interact with TLR9, TLR4, IL-1R, and TLR2 receptors, respectively. Thus, HMGB1 has dual activities, solo or in company; I speculate that this may serve our body's necessity to sacrifice or reconstruct tissues as required by the presence or absence of pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414536     DOI: 10.1189/jlb.1008585

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  179 in total

1.  Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4.

Authors:  Jianlin Chen; John R Hartono; Reji John; Michael Bennett; Xin Jin Zhou; Yanxia Wang; Qingqing Wu; Pamela D Winterberg; Glenn T Nagami; Christopher Y Lu
Journal:  Kidney Int       Date:  2011-06-01       Impact factor: 10.612

Review 2.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

Review 3.  HMGB1 and microparticles as mediators of the immune response to cell death.

Authors:  David S Pisetsky; Julie Gauley; Anirudh J Ullal
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

4.  The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1.

Authors:  Richard R Kew; Marianna Penzo; David M Habiel; Kenneth B Marcu
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

5.  HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2.

Authors:  Man Sup Kwak; Mihwa Lim; Yong Joon Lee; Hyun Sook Lee; Young Hun Kim; Ju Ho Youn; Ji Eun Choi; Jeon-Soo Shin
Journal:  J Innate Immun       Date:  2015-02-05       Impact factor: 7.349

6.  Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells.

Authors:  Jong Ha Jung; Ji Hoon Park; Min Hyeok Jee; Sun Ju Keum; Min-Sun Cho; Seung Kew Yoon; Sung Key Jang
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 7.  Phagocyte partnership during the onset and resolution of inflammation.

Authors:  Oliver Soehnlein; Lennart Lindbom
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 8.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

Review 9.  Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.

Authors:  Simon Ducheix; Maria Carmela Vegliante; Gaetano Villani; Nicola Napoli; Carlo Sabbà; Antonio Moschetta
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

Review 10.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.